The incidence and influencing factors of in-hospital frailty progression following transcatheter aortic valve implantation.

AS Clinical Frailty Scale Frailty progression TAVI TAVR

Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
09 May 2024
Historique:
medline: 9 5 2024
pubmed: 9 5 2024
entrez: 8 5 2024
Statut: aheadofprint

Résumé

Objective Patients undergoing transcatheter aortic valve implantation (TAVI) are generally older and frailty is therefore an important clinical issue. The baseline degree of frailty is associated with the prognosis in patients undergoing TAVI; however, the incidence of in-hospital frailty progression and its influencing factors have not yet been elucidated. Methods This observational, single-center study retrospectively evaluated 281 patients who underwent TAVI. The degree of frailty at baseline and discharge was evaluated using the Clinical Frailty Scale (CFS). In-hospital frailty progression was defined as an increase of at least one level in the CFS score at discharge from baseline, and predictors of frailty progression were assessed. Results The median baseline CFS score was 4.0 (interquartile range: 3.0-4.0). In-hospital frailty progression was observed in 49 patients (17.4%). No significant differences were observed in age, sex, comorbidities, or surgical risk scores between patients with and without frailty progression. Patients with frailty progression experienced stroke more frequently during hospitalization than those without (12.2% vs. 1.3%, p = 0.001). A multivariable logistic analysis showed that in-hospital stroke was a significant predictor of frailty progression (odds ratio, 10.7; 95% confidence interval: 2.34-49.2, p = 0.002). Patients with frailty progression had a longer hospital stay than those without frailty progression [7.0 (4.0-17.0) vs. 4.0 (4.0-8.0) days, p = 0.001]. Conclusions In-hospital frailty progression was not uncommon in patients undergoing TAVI. Stroke incidence was a significant influencing factor in frailty progression, whereas baseline comorbidities and surgical risks were not.

Identifiants

pubmed: 38719603
doi: 10.2169/internalmedicine.3146-23
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Tatsuya Miyazaki (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.

Akihito Tanaka (A)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.

Yoshiyuki Tokuda (Y)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Japan.

Yoshinori Shirai (Y)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.

Koji Mizutani (K)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.

Kenji Furusawa (K)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.

Sho Akita (S)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Japan.

Takahiro Ozeki (T)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Japan.

Kiyonori Kobayashi (K)

Department of Rehabilitation, Nagoya University Hospital, Japan.

Hideki Ishii (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.
Department of Cardiology, Gunma University Graduate School of Medicine, Japan.

Masato Mutsuga (M)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Japan.

Classifications MeSH